Glimitos MV 1mg/500mg/0.3mg Tablet
Marketer
Atos Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimitos MV 1mg/500mg/0.3mg Tablet
Diabexe Trio (1mg/500mg/0.3mg) tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This formulation helps regulate blood glucose levels. Diabexe Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to manage them. Maintain regular meals and carry readily available glucose sources (e.g., sugary snacks, juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor about any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your physician may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glimitos MV 1mg/500mg/0.3mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimitos MV 1mg/500mg/0.3mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glimitos MV 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing. Consume the Glimitos MV 1mg/500mg/0.3mg tablet on an empty stomach.
Common Side effects of Glimitos MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimitos MV 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume the Glimitos MV 1mg/500mg/0.3mg tablet on an empty stomach.
How Glimitos MV 1mg/500mg/0.3mg Tablet works:
One tablet of Glimitos MV contains 1 mg, 500 mg, and 0.3 mg of three different antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Glimitos MV 1mg/500mg/0.3mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitos MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimitos MV 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Glimitos MV 1mg/500mg/0.3mg Tablets, as their use may be unsafe. Medical advice is necessary. This medication is also contraindicated in patients exhibiting severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Glimitos MV 1mg/500mg/0.3mg tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should begin with a low dose. Glimitos MV 1mg/500mg/0.3mg tablets are contraindicated in patients with severe liver disease. Medical advice is recommended.
What if you forget to take Glimitos MV 1mg/500mg/0.3mg Tablet :
Should you forget a Glimitos MV 1mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimitos MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently